Augment Health

Augment Health

Pre-clinical
San Francisco, United StatesFounded 2019augment.health

Augment Health is pioneering smart medical devices for bladder monitoring, specifically targeting the complex needs of patients with neurological conditions like spinal cord injury, multiple sclerosis, and Parkinson's disease. The company emphasizes a holistic design philosophy that considers both psychological and physical well-being, differentiating its approach in the digital health and medtech space. While specific pipeline details and leadership are not publicly disclosed on their minimal website, their focus addresses a critical gap in chronic care management for neurogenic bladder dysfunction. Their strategic direction likely involves developing non-invasive or minimally invasive monitoring systems to prevent complications and enhance patient independence.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Total funding raised: $2.5M

AI Company Overview

Augment Health is pioneering smart medical devices for bladder monitoring, specifically targeting the complex needs of patients with neurological conditions like spinal cord injury, multiple sclerosis, and Parkinson's disease. The company emphasizes a holistic design philosophy that considers both psychological and physical well-being, differentiating its approach in the digital health and medtech space. While specific pipeline details and leadership are not publicly disclosed on their minimal website, their focus addresses a critical gap in chronic care management for neurogenic bladder dysfunction. Their strategic direction likely involves developing non-invasive or minimally invasive monitoring systems to prevent complications and enhance patient independence.

UrologyNeurology

Technology Platform

Smart bladder monitoring platform designed with integrated psychological and physical health considerations for patients with neurological conditions.

Funding History

1
Total raised:$2.5M
Seed$2.5MAug 15, 2021

Opportunities

Large and growing patient population with neurogenic bladder dysfunction; shift towards remote patient monitoring and value-based care; potential to reduce high-cost complications like hospitalizations; opportunity to integrate with broader neurological and urological care ecosystems.

Risk Factors

Regulatory hurdles for medical device clearance; challenges in proving clinical utility and securing insurance reimbursement; usability and adoption barriers in a patient population with physical limitations; competition from established medtech companies and emerging digital health startups.

Competitive Landscape

Competes against large medtech firms (e.g., Medtronic, Coloplast) offering traditional devices and against emerging digital health startups in urology. Key differentiation is the explicit design focus on integrating psychological and physical health, aiming for better patient engagement and holistic outcomes in neurogenic bladder management.